Australia Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

  • ID: 4342759
  • Report
  • Region: Australia
  • 132 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • AstraZeneca Plc
  • Baxter International Inc
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline Plc
  • Medtronic plc
  • Nipro Corp
  • MORE
Australia Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

Summary

The new report, "Australia Drug Delivery Devices Market Outlook to 2023", provides key market data on the Australia Drug Delivery Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories - Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
  • Market size and company share data for Drug Delivery Devices market categories - Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.
  • Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2009 to 2016 and forecast to 2023.
  • 2016 company shares and distribution shares data for each of the market categories.
  • Global corporate-level profiles of key companies operating within the Australia Drug Delivery Devices market.
  • Key players covered include GlaxoSmithKline Plc, AstraZeneca Plc, Hospira Inc, Becton Dickinson and Co, Boehringer Ingelheim GmbH, Baxter International Inc, Medtronic plc and others.
Reasons to buy
  • Develop business strategies by identifying the key market categories poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AstraZeneca Plc
  • Baxter International Inc
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline Plc
  • Medtronic plc
  • Nipro Corp
  • MORE
1 Table of Contents
2 Introduction
2.1 What Is This Report About?
2.2 Drug Delivery Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Drug Delivery Devices Market, Australia
3.1 Drug Delivery Devices Market, Australia, Revenue ($m), 2009-2023
3.2 Drug Delivery Devices Market, Australia, Revenue Mix ($m), 2016
3.3 Drug Delivery Devices Market, Australia, Category Contribution by Revenue ($m), 2016
3.4 Drug Delivery Devices Market, Australia, Category Comparison by Revenue ($m), 2009-2023
3.5 Drug Delivery Devices Market, Australia, Revenue ($m), 2009-2016
3.6 Drug Delivery Devices Market, Australia, Revenue ($m), 2016-2023
3.7 Drug Delivery Devices Market, Australia, Volume (Units), 2009-2023
3.8 Drug Delivery Devices Market, Australia, Volume (Units), 2009-2016
3.9 Drug Delivery Devices Market, Australia, Volume (Units), 2016-2023
3.10 Drug Delivery Devices Market, Australia, Company Share by Revenue ($m), 2016
4 Central Venous Catheters Market, Australia
4.1 Central Venous Catheters Market, Australia, Revenue Mix ($m), 2016
4.2 Central Venous Catheters Market, Australia, Segment Contribution (%), 2016
4.3 Central Venous Catheters Market, Australia, Revenue ($m), 2009-2016
4.4 Central Venous Catheters Market, Australia, Revenue ($m), 2016-2023
4.5 Central Venous Catheters Market, Australia, Volume (Units), 2009-2016
4.6 Central Venous Catheters Market, Australia, Volume (Units), 2016-2023
4.7 Central Venous Catheters Market, Australia, Distribution Share by Revenue ($m), 2015-2016
4.8 Central Venous Catheters Market, Australia, Company Share by Revenue ($m), 2016
5 Infusion Systems Market, Australia
5.1 Infusion Systems Market, Australia, Revenue Mix ($m), 2016
5.2 Infusion Systems Market, Australia, Segment Contribution (%), 2016
5.3 Infusion Systems Market, Australia, Revenue ($m), 2009-2016
5.4 Infusion Systems Market, Australia, Revenue ($m), 2016-2023
5.4.1 Ambulatory Infusion Pumps Market, Australia, Revenue ($m), by Segment, 2009-2016
5.4.2 Syringe Pumps Market, Australia, Revenue ($m), by Segment, 2009-2016
5.4.3 Ambulatory Infusion Pumps Market, Australia, Revenue ($m), by Segment, 2016-2023
5.4.4 Syringe Pumps Market, Australia, Revenue ($m), by Segment, 2016-2023
5.5 Infusion Systems Market, Australia, Volume (Units), 2009-2016
5.6 Infusion Systems Market, Australia, Volume (Units), 2016-2023
5.6.1 Ambulatory Infusion Pumps Market, Australia, Volume (Units), by Segment, 2009-2016
5.6.2 Syringe Pumps Market, Australia, Volume (Units), by Segment, 2009-2016
5.6.3 Ambulatory Infusion Pumps Market, Australia, Volume (Units), by Segment, 2016-2023
5.6.4 Syringe Pumps Market, Australia, Volume (Units), by Segment, 2016-2023
5.7 Infusion Systems Market, Australia, Distribution Share by Revenue ($m), 2015-2016
5.8 Infusion Systems Market, Australia, Company Share by Revenue ($m), 2016
6 Needle Free Injections Market, Australia
6.1 Needle Free Injections Market, Australia, Revenue ($m), 2009-2016
6.2 Needle Free Injections Market, Australia, Revenue ($m), 2016-2023
6.3 Needle Free Injections Market, Australia, Volume (Units), 2009-2016
6.4 Needle Free Injections Market, Australia, Volume (Units), 2016-2023
6.5 Needle Free Injections Market, Australia, Distribution Share by Revenue ($m), 2015-2016
6.6 Needle Free Injections Market, Australia, Company Share by Revenue ($m), 2016
7 Metered Dose Inhaler Devices Market, Australia
7.1 Metered Dose Inhaler Devices Market, Australia, Revenue ($m), 2009-2016
7.2 Metered Dose Inhaler Devices Market, Australia, Revenue ($m), 2016-2023
7.3 Metered Dose Inhaler Devices Market, Australia, Volume (Units), 2009-2016
7.4 Metered Dose Inhaler Devices Market, Australia, Volume (Units), 2016-2023
7.5 Metered Dose Inhaler Devices Market, Australia, Distribution Share by Revenue ($m), 2015-2016
7.6 Metered Dose Inhaler Devices Market, Australia, Company Share by Revenue ($m), 2016
8 Overview of Key Companies in Australia, Drug Delivery Devices Market
8.1 Teleflex Inc
8.1.1 Company Overview
8.2 GlaxoSmithKline Plc
8.2.1 Company Overview
8.3 AstraZeneca Plc
8.3.1 Company Overview
8.4 Becton Dickinson and Co
8.4.1 Company Overview
8.5 Boehringer Ingelheim GmbH
8.5.1 Company Overview
8.6 Baxter International Inc
8.6.1 Company Overview
8.7 Fresenius Kabi AG
8.7.1 Company Overview
8.8 Pfizer Inc
8.8.1 Company Overview
8.9 B. Braun Melsungen AG
8.9.1 Company Overview
8.10 Smiths Medical
8.10.1 Company Overview
8.11 Merck & Co Inc
8.11.1 Company Overview
8.12 Hospira Inc
8.12.1 Company Overview
8.13 Terumo Corp
8.13.1 Company Overview
8.14 Nipro Corp
8.14.1 Company Overview
8.15 Medtronic plc
8.19.1 Company Overview
9 Drug Delivery Devices Market Pipeline Products
10 Financial Deals Landscape
10.1 Asset Transactions
10.1.1 ICU Medical Acquires Hospira Infusion Systems Business from Pfizer
10.2 Debt Offerings
10.2.1 Suda to Raise USD0.6 Million in Public Offering of 8% Convertible Notes Due March 2019
10.3 Equity Offerings
10.3.1 Suda Raises USD1.1 Million in Private Placement of Shares
10.3.2 Admedus Raises USD7.5 Million in Private Placement of Shares
10.3.3 Admedus Raises USD4 Million in Rights Offering of Shares
10.4 Partnerships
10.4.1 Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs
10.4.2 Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma
10.4.3 Pfizer Terminates its Licensing Agreement with pSivida
10.4.4 Bayer Enters into Licensing Agreement with DelSiTech
10.4.5 BioCorRx Enters into Licensing Agreement with Therakine
11 Recent Developments
11.1 Corporate Communications
11.1.1 Jun 09, 2017: Admedus Appoints David St. Denis as Chief Operating Officer
11.1.2 May 23, 2017: Analytica: Appointment of Dr. Peter B. Corr as Director
11.1.3 Apr 21, 2017: Phosphagenics Announces Transition of Chairman of the Board
11.1.4 Apr 04, 2017: GSK responds to Cyclone Debbie
11.1.5 Mar 15, 2017: Admedus Appoints Wayne Paterson As Chief Executive Officer
11.1.6 Mar 14, 2017: Admedus Appoints John Seaberg As Chairman
11.1.7 Dec 12, 2016: Cologuard Available to Humana Members as In-Network Colon Cancer Screening Option
11.1.8 Dec 08, 2016: Acrux Announces Director Resignation
11.1.9 Oct 17, 2016: Medrobotics Corporation Receives Expanded CE Mark for Flex Robotic System
11.1.10 Sep 25, 2016: Admedus Strengthens Management Team
11.1.11 Sep 15, 2016: Anne Belcher to succeed Geoff McDonald as GSK Australia general manager
11.1.12 Aug 26, 2016: Admedus Appoints New Chief Financial Officer
11.2 Financial Announcements
11.2.1 May 02, 2017: GSK Australia Reports 2016 results to ASIC
11.2.2 Apr 28, 2017: Clinuvel Pharmaceuticals: Appendix 4C - Quarterly report
11.2.3 Feb 28, 2017: Phosphagenics Full Year Financial Results
11.2.4 Feb 24, 2017: Admedus Announces Half Yearly Report
11.2.5 Feb 23, 2017: ITL Profit Doubles In Half Year 2016/2017 Results
11.2.6 Feb 20, 2017: Medical Developments Reports Revenue Of AUD8m In H1 Fiscal 2017
11.2.7 Oct 31, 2016: Suda: Appendix 4C For First Quarter Fy 2017
11.2.8 Oct 28, 2016: Analytica: Appendix 4C - Quarterly Cash Flow Report
11.2.9 Aug 31, 2016: Analytica Announces 2016 Full Year Results
11.2.10 Aug 24, 2016: Acrux: Financial Report for the year ended 30 June 2016
11.2.11 Jul 20, 2016: Admedus Announces Financial Report
11.3 Legal And Regulatory
11.3.1 May 29, 2017: Phosphagenic - Mylan Arbitration Update - expert report on quantum of damages claimed filed
11.3.2 Jan 20, 2017: Change of Registered Office and Principal Place of Business
11.3.3 Sep 09, 2016: Admedus Announces Settlement Of Federal Court Proceedings
11.4 Other Significant Developments
11.4.1 Apr 26, 2017: Axiron Net Sales, quarter to March 2017
11.4.2 Apr 13, 2017: PreveCeutical Signs Letter of Intent for Research & Development for Cannabinoid and Diabetes Products with UniQuest
11.4.3 Mar 07, 2017: Anteo Technologies Announces Verification Study With Cook Medical Australia
11.4.4 Jan 31, 2017: Analytica Releases Quarterly Cash Flow Report
11.4.5 Dec 23, 2016: Admedus Finishes Year With Growing Revenue After Completing Code Red Review
11.4.6 Oct 28, 2016: Starpharma Quarterly Cashflow Report
11.5 Product News
11.5.1 Oct 26, 2016: Starpharma to present at US Drug Delivery Conference
12 Appendix
12.1 Research Methodology
12.1.1 Coverage
12.1.2 Secondary Research
12.1.3 Primary Research
12.1.4 Company Share Analysis
12.1.5 Distribution Share Analysis
12.1.6 Benchmarking
12.2 Consulting
12.3 Contact
12.4 Disclaimer

List of Tables
Table 1: Drug Delivery Devices Market, Australia, Revenue ($m), USD Constant, 2009-2023
Table 2: Drug Delivery Devices Market, Australia, Category Contribution by Revenue ($m), 2016
Table 3: Drug Delivery Devices Market, Australia, Category Comparison by Revenue ($m), 2009-2023
Table 4: Drug Delivery Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016
Table 5: Drug Delivery Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 6: Drug Delivery Devices Market, Australia, Volume (Units), 2009-2023
Table 7: Drug Delivery Devices Market, Australia, Volume (Units), Historic, 2009-2016
Table 8: Drug Delivery Devices Market, Australia, Volume (Units), Forecast, 2016-2023
Table 9: Drug Delivery Devices Market, Australia, Company Share by Revenue ($m), USD Constant, 2016
Table 10: Central Venous Catheters Market, Australia, Segment Contribution (%), 2016
Table 11: Central Venous Catheters Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016
Table 12: Central Venous Catheters Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 13: Central Venous Catheters Market, Australia, Volume (Units), Historic, 2009-2016
Table 14: Central Venous Catheters Market, Australia, Volume (Units), Forecast, 2016-2023
Table 15: Central Venous Catheters Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 16: Central Venous Catheters Market, Australia, Company Share by Revenue ($m), USD Constant, 2016
Table 17: Infusion Systems Market, Australia, Segment Contribution (%), 2016
Table 18: Infusion Systems Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016
Table 19: Infusion Systems Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 20: Ambulatory Infusion Pumps Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016
Table 21: Syringe Pumps Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016
Table 22: Ambulatory Infusion Pumps Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 23: Syringe Pumps Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 24: Infusion Systems Market, Australia, Volume (Units), Historic, 2009-2016
Table 25: Infusion Systems Market, Australia, Volume (Units), Forecast, 2016-2023
Table 26: Ambulatory Infusion Pumps Market, Australia, Volume (Units), Historic, 2009-2016
Table 27: Syringe Pumps Market, Australia, Volume (Units), Historic, 2009-2016
Table 28: Ambulatory Infusion Pumps Market, Australia, Volume (Units), Forecast, 2016-2023
Table 29: Syringe Pumps Market, Australia, Volume (Units), Forecast, 2016-2023
Table 30: Infusion Systems Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 31: Infusion Systems Market, Australia, Company Share by Revenue ($m), USD Constant, 2016
Table 32: Needle Free Injections Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016
Table 33: Needle Free Injections Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 34: Needle Free Injections Market, Australia, Volume (Units), Historic, 2009-2016
Table 35: Needle Free Injections Market, Australia, Volume (Units), Forecast, 2016-2023
Table 36: Needle Free Injections Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 37: Needle Free Injections Market, Australia, Company Share by Revenue ($m), USD Constant, 2016
Table 38: Metered Dose Inhaler Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016
Table 39: Metered Dose Inhaler Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 40: Metered Dose Inhaler Devices Market, Australia, Volume (Units), Historic, 2009-2016
Table 41: Metered Dose Inhaler Devices Market, Australia, Volume (Units), Forecast, 2016-2023
Table 42: Metered Dose Inhaler Devices Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 43: Metered Dose Inhaler Devices Market, Australia, Company Share by Revenue ($m), USD Constant, 2016
Table 44: Drug Delivery Devices Market Pipeline Products
Table 45: ICU Medical Acquires Hospira Infusion Systems Business from Pfizer
Table 46: Suda to Raise USD0.6 Million in Public Offering of 8% Convertible Notes Due March 2019
Table 47: Suda Raises USD1.1 Million in Private Placement of Shares
Table 48: Admedus Raises USD7.5 Million in Private Placement of Shares
Table 49: Admedus Raises USD4 Million in Rights Offering of Shares
Table 50: Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs
Table 51: Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma
Table 52: Pfizer Terminates its Licensing Agreement with pSivida
Table 53: Bayer Enters into Licensing Agreement with DelSiTech
Table 54: BioCorRx Enters into Licensing Agreement with Therakine

List of Figures
Figure 1: Drug Delivery Devices Market, Australia, Revenue ($m), USD Constant, 2009-2023
Figure 2: Drug Delivery Devices Market, Australia, Revenue Mix ($m), 2016
Figure 3: Drug Delivery Devices Market, Australia, Category Contribution (%), 2016
Figure 4: Drug Delivery Devices Market, Australia, Category Comparison by Revenue ($m), 2009-2023
Figure 5: Drug Delivery Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 6: Drug Delivery Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 7: Drug Delivery Devices Market, Australia, Volume (Units), 2009-2023
Figure 8: Drug Delivery Devices Market, Australia, Volume (Units), Historic, 2009-2016
Figure 9: Drug Delivery Devices Market, Australia, Volume (Units), Forecast, 2016-2023
Figure 10: Drug Delivery Devices Market, Australia, Company Share (%) 2016
Figure 11: Central Venous Catheters Market, Australia, Revenue Mix ($m), 2016
Figure 12: Central Venous Catheters Market, Australia, Segment Contribution (%), 2016
Figure 13: Central Venous Catheters Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 14: Central Venous Catheters Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 15: Central Venous Catheters Market, Australia, Volume (Units), Historic, 2009-2016
Figure 16: Central Venous Catheters Market, Australia, Volume (Units), Forecast, 2016-2023
Figure 17: Central Venous Catheters Market, Australia, Company Share (%) 2016
Figure 18: Infusion Systems Market, Australia, Revenue Mix ($m), 2016
Figure 19: Infusion Systems Market, Australia, Segment Contribution (%), 2016
Figure 20: Infusion Systems Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 21: Infusion Systems Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 22: Ambulatory Infusion Pumps Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 23: Syringe Pumps Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 24: Ambulatory Infusion Pumps Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 25: Syringe Pumps Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 26: Infusion Systems Market, Australia, Volume (Units), Historic, 2009-2016
Figure 27: Infusion Systems Market, Australia, Volume (Units), Forecast, 2016-2023
Figure 28: Ambulatory Infusion Pumps Market, Australia, Volume (Units), Historic, 2009-2016
Figure 29: Syringe Pumps Market, Australia, Volume (Units), Historic, 2009-2016
Figure 30: Ambulatory Infusion Pumps Market, Australia, Volume (Units), Forecast, 2016-2023
Figure 31: Syringe Pumps Market, Australia, Volume (Units), Forecast, 2016-2023
Figure 32: Infusion Systems Market, Australia, Company Share (%) 2016
Figure 33: Needle Free Injections Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 34: Needle Free Injections Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 35: Needle Free Injections Market, Australia, Volume (Units), Historic, 2009-2016
Figure 36: Needle Free Injections Market, Australia, Volume (Units), Forecast, 2016-2023
Figure 37: Needle Free Injections Market, Australia, Company Share (%) 2016
Figure 38: Metered Dose Inhaler Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 39: Metered Dose Inhaler Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 40: Metered Dose Inhaler Devices Market, Australia, Volume (Units), Historic, 2009-2016
Figure 41: Metered Dose Inhaler Devices Market, Australia, Volume (Units), Forecast, 2016-2023
Figure 42: Metered Dose Inhaler Devices Market, Australia, Company Share (%) 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Teleflex Inc
  • GlaxoSmithKline Plc
  • AstraZeneca Plc
  • Becton Dickinson and Co
  • Boehringer Ingelheim GmbH
  • Baxter International Inc
  • Fresenius Kabi AG
  • Pfizer Inc
  • B. Braun Melsungen AG
  • Smiths Medical
  • Merck & Co Inc
  • Hospira Inc
  • Terumo Corp
  • Nipro Corp
  • Medtronic plc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll